Yanqiu Zhao, MD

Director of Department of Medical Oncology
The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, China (People's Republic)

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025